Insider trades

Atabak Mokari, CFO of Corcept Therapeutics CORT, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $6M. The latest trade was on 06/15.

Atabak Mokari

CFO
First filing
23/02/15
Trades
51 trades
Buys / sales
0 / 5
12-month net buying
−$6M
Last trade
06/15

Trading activity

Transactions

Trade type
CORT
Open-market sale10b5-1 plan06/1506/1740,000 sh4 trades$81.15avg.$3,245,873.95−71.3%
Open-market sale10b5-1 plan06/0106/0340,000 sh$70.00$2,800,000−72.4%